Gout flareInterleukin-1βRandomised controlled trialsCanakinumabRilonaceptAnakinraThe objective of this systematic review was to assess the effects of interleukin-1尾 (IL-1尾) inhibitors on gout flares.#Studies published between 2011 and 2022 that evaluated the effects of IL-1尾 inhibitors in adult ...
SAT0502 Comparison between Oral or Intra-Articular Corticoids in the Management of Acute Gout Flare in Patients with Chronic Renal FailureAnimalsPyrethrinsChlorpyrifosInsecticidesDrug CombinationsBehavior, AnimalTime FactorsReduviidaeFemaleMaleThe article discusses a study describing the impact of the ...
The first concept is to help patients understand that gout is purely a disease of urate burden. The stages are asymptomatic hyperuricemia, acute and intermittent gouty symptoms, and chronic tophaceous, or advanced, gout. Edwards stressed, however, that as the symptoms fl...
Gout is common in the elderly and its management is frequently complicated by the presence of co-morbid conditions and medications prescribed for other conditions. The management of gout is 2-fold: (i) treatment of the acute attack to rapidly resolve the pain and inflammation; and (ii) long-...
Objective. Management of gout is frequently suboptimal. The aim of this study was to determine the proportion of patients presenting to Christchurch Hospital for a gout flare and to determine whether management for both acute flares and urate lowering was in accordance with international ...
34% of patients who had acute gout during hospitalization had a polyarticular attack. Most patients had significant comorbidities such as diabetes (39%), chronic kidney disease (60%) and coronary artery disease (43%). Among the patients with an acute gout flare (n=38), common treatments ...
gouturate-lowering therapypegloticaseuricaseurate oxidaseimmunogenicityGout is a debilitating disease secondary to chronic hyperuricemia, and the subsequent deposition of monosodium urate crystals is responsible for acute flare, gout arthropathies, tophi and renal lithiasis. Uric acid is the end product ...
These anti-inflammatory drugs that are used to treat acute gout are discussed in detail. Their administration, pharmacology, and toxicity are considered. Then, urate-lowering therapy is thoroughly described, again considering the administration, pharmaco
Prevention and Management of GoutAn acute gout flare is a common cause for ambulatory and emergency department (ED) visits. This teaching script leads the reader through an initial approach to abortive treatment, and moves on to cover nonpharmacologic and pharmacologic strategies of flare prevention....
For those patients that received prophylaxis and were compliant, only 20% (5/24) had a flare of their gout, whilst 60% (3/5) of patients not on prophylaxis encountered an attack.Post ULA treatment, only 22% achieved their respective target of <300渭mol/L. On review of the target ...